| Device |
hospital continuous glucose monitoring system |
| Regulation Description |
Glucose test system. |
| Definition |
Intended for the continuous, quantitative measurement of glucose in whole blood in a hospital setting. |
| Physical State |
The device system is comprised of a cartridge and an instrument that measures and displays the result. |
| Technical Method |
The operator connects the device to the blood source of the patient and activates the assay. |
| Target Area |
Whole blood. |
| Regulation Medical Specialty |
Clinical Chemistry |
| Review Panel |
Clinical Chemistry |
| Product Code | PYV |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Chemistry and Toxicology Devices
(DCTD)
|
| Submission Type |
510(k)
|
| Regulation Number |
862.1345
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |